Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.
Transform life sciences with AI-driven data strategies for impactful insights across the product lifecycle.
Learn about our data strategy and analytics services for pharmaceutical companies in the life science industry.
Mobile navigation menu modal
Explore our latest insights and perspectives in these life science resources, news articles, and events.
China is emerging as a global oncology innovation hub, reshaping clinical development, dealmaking, and advanced therapy sourcing worldwide.
Discover how Medical Affairs can shift from activity metrics to impact-driven strategies with AI and analytics. Read the full report.
Discover how to select the right preference method DCE, BWS, MDT or OPUF for rare diseases and small sample studies.
Explore a new model for antibiotic investment—driven by AMR, evolving P&R frameworks, and key indicators shaping commercial strategy.
Explore how CMS set 2024 drug MFPs under the IRA—insights, data drivers & pharma strategies for future Medicare negotiations.
Discover how AI & claims data are transforming Medical Affairs in this MAPS webinar with experts from Putnam, Genentech & more.
Discover insights into the evolving US vaccine landscape, trends, and strategic imperatives for successful novel vaccine launches. Download now!
Putnam experts share observations on recent global trends in the rare disease space and recommend strategies to maximize opportunities.
Are you interested in equity in health and looking to capture the wider value of your assets? Watch this webcast to find out more!
Watch this webcast, in which our expert panellists discuss common challenges faced during the product launch journey.
Targeted radiopharmaceuticals are transforming cancer treatment and may become the ultimate focal therapy.
Learn how Putnam reviewed the paths took by five prominent biotech companies to establish itself as a successful commercial-stage organization.
Looking to get in touch with an expert or team member?
Tell us how we can help.
